Literature DB >> 30554075

Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide.

Adan Rios1, Putao Cen2, Brian Dinh3, Steven R Mays4, Anisha B Patel5.   

Abstract

Entities:  

Keywords:  Etoposide; Immune checkpoint inhibitor; Immune-related adverse events; T-cell activation

Mesh：

Substances：

Year:  2018        PMID： 30554075     DOI： 10.1016/j.ejca.2018.11.025

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Chronic and Severe Non-Lichenoid Oral Ulcers Induced by Nivolumab - Diagnostic and Therapeutic Challenge: A Case Report.

Authors:  Andrés F Cardona; Alejandro Ruiz-Patiño; Luisa Ricaurte; Zyanya Lucia Zatarain-Barrón; Feliciano Barrón; Oscar Arrieta
Journal:  Case Rep Oncol       Date:  2020-03-25

2.  Anticancer Potential of Damnacanthal and Nordamnacanthal from Morinda elliptica Roots on T-lymphoblastic Leukemia Cells.

Authors:  Saiful Yazan Latifah; Banulata Gopalsamy; Raha Abdul Rahim; Abdul Manaf Ali; Nordin Haji Lajis
Journal:  Molecules       Date:  2021-03-12       Impact factor: 4.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.